Publikationen (66) Publikationen von Antonio Martínez de la Cuesta

2024

  1. The Impact of Portal Hypertension Assessment Method on the Outcomes of Hepatocellular Carcinoma Resection: A Meta-Analysis of Matched Cohort and Prospective Studies

    Annals of Surgery, Vol. 280, Núm. 1, pp. 46-55

2023

  1. Correction to: Prostatic Artery Embolization (PAE) Using Polyethylene Glycol Microspheres: Safety and Efficacy in 81 Patients (CardioVascular and Interventional Radiology, (2022), 45, 9, (1339-1348), 10.1007/s00270-022-03165-4)

    CardioVascular and Interventional Radiology

  2. Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience

    Cancers, Vol. 15, Núm. 3

  3. Partial Radiation Nephrectomy Using 90Y Resin Microspheres: A Treatment Option for Renal Tumors With Malignant Characteristics in Patients Not Candidates for Surgery

    Clinical Nuclear Medicine, Vol. 48, Núm. 11, pp. 960-962

  4. Radioembolization with yttrium as neoadjuvant therapy in initially unresectable intrahepatic cholangiocarcinoma

    Cirugia Espanola, Vol. 101, Núm. 2, pp. 143-145

  5. Surgery and radioembolization of liver tumors

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 4, pp. 265-271

2022

  1. Prostatic Artery Embolization (PAE) Using Polyethylene Glycol Microspheres: Safety and Efficacy in 81 Patients

    CardioVascular and Interventional Radiology, Vol. 45, Núm. 9, pp. 1339-1348

2021

  1. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 5, pp. 1570-1584

  2. The joint use of 99mTc-MAA-SPECT/CT and cone-beam CT optimizes radioembolization planning

    EJNMMI Research, Vol. 11, Núm. 1

2020

  1. Portal-Mesenteric Venous Thrombosis

    Image-Guided Interventions: Expert Radiology Series, Third Edition (Elsevier), pp. 603-610.e1

2019

  1. Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial

    British Journal of Surgery, Vol. 106, Núm. 13, pp. 1837-1846

2015

  1. Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma

    Liver International, Vol. 35, Núm. 6, pp. 1715-1721

2011

  1. Diagnosis and management of extensive vascular malformations of the lower limb: Part I. Clinical diagnosis

    Journal of the American Academy of Dermatology, Vol. 65, Núm. 5, pp. 893-906

  2. Diagnosis and management of extensive vascular malformations of the lower limb: Part II. Systemic repercusion, diagnosis, and treatment

    Journal of the American Academy of Dermatology, Vol. 65, Núm. 5, pp. 909-923

  3. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages

    Annals of Surgical Oncology, Vol. 18, Núm. 7, pp. 1964-1971

2010

  1. Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma

    International Journal of Radiation Oncology Biology Physics, Vol. 77, Núm. 5, pp. 1441-1448

  2. Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: Implications for antiangiogenic/antithrombotic strategies

    British Journal of Dermatology, Vol. 162, Núm. 2, pp. 350-356

  3. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis

    Journal of Vascular and Interventional Radiology, Vol. 21, Núm. 8, pp. 1205-1212

  4. Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors

    CardioVascular and Interventional Radiology, Vol. 33, Núm. 3, pp. 523-531

2009

  1. A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma

    Hepato-Gastroenterology, Vol. 56, Núm. 96, pp. 1683-1688